Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIV.
Simsek A, Bessen C, Meister TL, Urlaub D, Skaletz-Rorowski A, Brockmeyer NH, Overheu O, Reinacher-Schick A, Faissner S, Watzl C, Pfaender S, Schmitz I, Potthoff A, Plaza-Sirvent C. Simsek A, et al. Among authors: meister tl. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):e825-e827. doi: 10.1111/jdv.19036. Epub 2023 Mar 24. J Eur Acad Dermatol Venereol. 2023. PMID: 36912717 No abstract available.
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse.
Westhoff TH, Seibert FS, Anft M, Blazquez-Navarro A, Skrzypczyk S, Zgoura P, Meister TL, Pfaender S, Stumpf J, Hugo C, Viebahn R, Roch T, Stervbo U, Babel N. Westhoff TH, et al. Among authors: meister tl. Kidney Int. 2021 Nov;100(5):1135-1136. doi: 10.1016/j.kint.2021.09.001. Epub 2021 Sep 9. Kidney Int. 2021. PMID: 34509489 Free PMC article. No abstract available.
Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19.
Paniskaki K, Konik MJ, Anft M, Heidecke H, Meister TL, Pfaender S, Krawczyk A, Zettler M, Jäger J, Gaeckler A, Dolff S, Westhoff TH, Rohn H, Stervbo U, Scheibenbogen C, Witzke O, Babel N. Paniskaki K, et al. Among authors: meister tl. Front Microbiol. 2023 Jun 2;14:1196721. doi: 10.3389/fmicb.2023.1196721. eCollection 2023. Front Microbiol. 2023. PMID: 37333646 Free PMC article.
Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination.
Paniskaki K, Anft M, Meister TL, Marheinecke C, Pfaender S, Skrzypczyk S, Seibert FS, Thieme CJ, Konik MJ, Dolff S, Anastasiou O, Holzer B, Dittmer U, Queren C, Fricke L, Rohn H, Westhoff TH, Witzke O, Stervbo U, Roch T, Babel N. Paniskaki K, et al. Among authors: meister tl. Front Immunol. 2022 Jan 25;13:816220. doi: 10.3389/fimmu.2022.816220. eCollection 2022. Front Immunol. 2022. PMID: 35145522 Free PMC article.
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination.
Paniskaki K, Konik MJ, Anft M, Meister TL, Marheinecke C, Pfaender S, Jäger J, Krawczyk A, Zettler M, Dolff S, Westhoff TH, Rohn H, Stervbo U, Witzke O, Babel N. Paniskaki K, et al. Among authors: meister tl. Front Immunol. 2022 Oct 31;13:1031254. doi: 10.3389/fimmu.2022.1031254. eCollection 2022. Front Immunol. 2022. PMID: 36389833 Free PMC article.
Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses.
Anft M, Blazquez-Navarro A, Frahnert M, Fricke L, Meister TL, Roch T, Stervbo U, Pfaender S, Westhoff TH, Babel N. Anft M, et al. Among authors: meister tl. Kidney Int. 2022 Jul;102(1):207-208. doi: 10.1016/j.kint.2022.05.004. Epub 2022 May 14. Kidney Int. 2022. PMID: 35580654 Free PMC article. No abstract available.
Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses.
Cinkilic O, Anft M, Blazquez-Navarro A, Meister TL, Roch T, Stervbo U, Pfaender S, Westhoff TH, Babel N. Cinkilic O, et al. Among authors: meister tl. Kidney Int. 2022 Jun;101(6):1287-1289. doi: 10.1016/j.kint.2022.03.005. Epub 2022 Mar 14. Kidney Int. 2022. PMID: 35301007 Free PMC article. No abstract available.
A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipients.
Roch T, Rohn B, Blazquez-Navarro A, Meister TL, Blanco EV, Paniskaki K, Wellenkötter J, Zgoura P, Giglio T, Pfaender S, Stervbo U, Viebahn R, Cinkilic O, Westhoff TH, Babel N. Roch T, et al. Among authors: meister tl. Kidney Int Rep. 2022 Apr;7(4):932-934. doi: 10.1016/j.ekir.2022.01.1068. Epub 2022 Feb 1. Kidney Int Rep. 2022. PMID: 35128216 Free PMC article. No abstract available.
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
Stegmann KM, Dickmanns A, Gerber S, Nikolova V, Klemke L, Manzini V, Schlösser D, Bierwirth C, Freund J, Sitte M, Lugert R, Salinas G, Meister TL, Pfaender S, Görlich D, Wollnik B, Groß U, Dobbelstein M. Stegmann KM, et al. Among authors: meister tl. Virus Res. 2021 Sep;302:198469. doi: 10.1016/j.virusres.2021.198469. Epub 2021 Jun 6. Virus Res. 2021. PMID: 34090962 Free PMC article.
59 results